What happens when the database is locked?
|
5
|
Resverlogix Corp.
|
Sep 01, 2019 02:47PM
|
Welcome to the party ABBV-744
|
6
|
Resverlogix Corp.
|
Feb 22, 2018 10:52AM
|
Wednesday 3/23/16
|
3
|
Resverlogix Corp.
|
Mar 18, 2016 08:49AM
|
Webcast is up
|
2
|
Resverlogix Corp.
|
Sep 12, 2018 05:07PM
|
We are now 12 months into BETonMACE dosing!
|
6
|
Resverlogix Corp.
|
Nov 11, 2016 12:09PM
|
Voyager, AAVs and Gene Targeted Therapies
|
2
|
BIOASIS TECHNOLOGIES INC
|
Feb 24, 2019 03:48PM
|
Vorapaxar and anti-platelet therapy
|
6
|
Resverlogix Corp.
|
Aug 10, 2018 12:44PM
|
Video presentation of Norman Wong's EASD poster from last week
|
1
|
Resverlogix Corp.
|
Sep 19, 2016 11:36AM
|
Victoza joins Jardiance as effective for reducing MACE in diabetics
|
4
|
Resverlogix Corp.
|
Mar 04, 2016 04:30PM
|
Very close to Final Draft of Checklist for Management - Included info from MD&A
|
2
|
Resverlogix Corp.
|
Jul 28, 2016 12:08PM
|
VCAM-1, Neuroinflammation and Neurodegeneration
|
5
|
Resverlogix Corp.
|
May 17, 2019 10:24AM
|
Uptick Newswire’s “Stock Day” Podcast Welcomes Dr. Mark Day of Bioasis Technologies Inc
|
|
BIOASIS TECHNOLOGIES INC
|
May 29, 2018 02:27PM
|
Updates on ClinicalTrials.gov
|
5
|
Resverlogix Corp.
|
Sep 26, 2018 02:44PM
|
Updates from RH
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jun 09, 2016 11:04AM
|
Updates from Mark Day
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jun 29, 2018 04:40PM
|
Updated Van Leeuwenhoeck Institute Analyst Report and August Fact Sheet
|
8
|
Resverlogix Corp.
|
Aug 02, 2018 05:06PM
|
Updated Van Leeuwenhoeck Analyst Report by Marcel Wijma 5/2/2019
|
8
|
Resverlogix Corp.
|
May 02, 2019 11:45PM
|
Updated Remaining Q2 2016 Events (RVX and Zenith)
|
2
|
Resverlogix Corp.
|
May 05, 2016 05:46PM
|
Updated Presentations and Publications Page
|
4
|
Resverlogix Corp.
|
Nov 20, 2015 01:55PM
|
Updated List of BET inhibitors
|
7
|
Zenith Epigenetics
|
Apr 10, 2019 02:03PM
|